Authors: HANTSON L TRITSMANS L CRABBE R GHEUENS J VANROOY P

Citation: L. Hantson et al., THE SAFETY AND TOLERABILITY OF SINGLE INTRAVENOUS DOSES OF LUBELUZOLE(PROSYNAP) IN HEALTHY-VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 35(11), 1997, pp. 491-495

Authors: DEKEYSER J VANDEVELDE V SCHELLENS RLLA HANTSON L TRITSMANS L GHEUENS J VANPEER A WOESTENBORGHS R FRANKE CL VANGORP J

Citation: J. Dekeyser et al., SAFETY AND PHARMACOKINETICS OF THE NEUROPROTECTIVE DRUG LUBELUZOLE INPATIENTS WITH ISCHEMIC STROKE, Clinical therapeutics, 19(6), 1997, pp. 1340-1351

Authors: TRITSMANS L BRISCOE P LEMMENS P VANDENBUSSCHE G

Citation: L. Tritsmans et al., PHARMACEUTICAL COMPANY TRIALS AND THE INTEGRITY OF MEDICAL-RESEARCH, Lancet, 347(9015), 1996, pp. 1628-1628

Authors: LEMMENS P DESMEDT G GHEUENS J TRITSMANS L

Citation: P. Lemmens et al., EFFICACY OF RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA, Schizophrenia research, 11(2), 1994, pp. 106-106

Authors: HANTSON L GHEUENS J TRITSMANS L DEKEYSER J

Citation: L. Hantson et al., HOSPITAL REFERRAL OF STROKE PATIENTS - A SURVEY OF ATTITUDES IN GENERAL-PRACTICE, AND CONSIDERATION OF ENTRY TIMES FOR CLINICAL-TRIALS, Clinical neurology and neurosurgery, 96(1), 1994, pp. 32-37